Back

Spinal Cord Stimulation in patients with Refractory Angina Pectoris (SCRAP); double-blind, placebo-controlled, cross-over randomized controlled trial

30 August 2026 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Innovative therapeutic strategies in coronary artery disease Nonpharmacological Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Fabienne Vervaat

Catharina Hospital, Eindhoven (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
The effects of STAtin-FENOfibrate combination therapy vs. statin monotherapy on necrotic core and plaque characteristics in non-diabetic patients with combined dyslipidemia and intermediate CAOD
Professor S. Han (Incheon, KR)
Abstract
Presentation thumbnail
Long-term adherence to secondary preventive medications after myocardial infarction: a post-hoc analysis of the BETAMI trial
Ms A. Bakken (Oslo, NO)
Abstract
Presentation thumbnail
Safety and efficacy of coronary sinus narrowing for treating refractory angina in real-world setting - single center experience
Ms J. Grygier (Poznan, PL)
Abstract
Presentation thumbnail
Natriuretic peptides reverse vascular insulin resistance and supress insulin-induced mechanisms of atherogenesis
Doctor D. Foran (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Innovative therapeutic strategies in coronary artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials
27 August 2021
thumbnail
Congress Presentation
Pain after subcutaneous ICD implantation: a secondary analysis of the PRAETORIAN-DFT trial
31 March 2025
thumbnail
Congress Presentation
Percutaneous stellate ganglion block and catheter ablation timing: new insights from the STAR study
12 April 2026
thumbnail
Congress Presentation
Safety, tolerability and diagnostic ability of a novel 18F-labelled tracer, [18F]SYN2, for PET myocardial perfusion imaging (SAFER) in patients with suspected coronary artery disease - phase II trial
20 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources